Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
Clinical Trial Listings
What are Clinical Trials?
Become a Clinical Trial Volunteer
Useful Resources
FDA Approved Drugs
Professional Resources
Research Center Profiles
Market Research
Benchmark Reports
FDA Approved Drugs
Training Guides
Books
eLearning
Events
Newsletters
White Papers
SOPs
White Papers
Clinical Trial Listings
Advertise
Sign In
Create Account
Sign Out
My Account
Home
»
Topics
»
News
» Clinical Intelligence
Clinical Intelligence
RSS
FDA approves first generic version of Lipitor
December 1, 2011
CenterWatch Staff
Omeros unlocks 20% of Class A orphans
November 30, 2011
CenterWatch Staff
BioMarin initiates phase II GALNS study
November 30, 2011
CenterWatch Staff
FDA accepts NDA for myeloma drug
November 29, 2011
CenterWatch Staff
Regeneron, Bayer initiate phase III SIGHT trial in China
November 28, 2011
CenterWatch Staff
FDA approves Intermezzo to treat insomnia
November 28, 2011
CenterWatch Staff
Boston Scientific's PROMUS Element Stent receives FDA approval
November 23, 2011
CenterWatch Staff
Bionovo enrolls first patient in phase III Menerba trial
November 22, 2011
CenterWatch Staff
FDA approves EYLEA injection
November 21, 2011
CenterWatch Staff
Cardica enrolls first patients in MicroCutter study
November 17, 2011
CenterWatch Staff
Previous
1
2
…
121
122
123
124
125
126
127
128
129
…
166
167
Next
Upcoming Events
23
Apr
Managing Data and Documentation for FDA Inspections and Remote Assessments
07
May
Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials
14
May
2024 Avoca Quality Consortium Summit
Featured Products
Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs
Best Practices for Clinical Trial Site Management
Featured Stories
Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials
Ask the Experts: Applying Quality by Design to Protocols
Clinical Trials Need Greater Representation of Obese Patients, Experts Say
FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
The information you need to adapt your monitoring plan to changing times.
Learn More Here